Our patented biomolecule copier is the basis for all our applications. We use it for the production and replication of all kinds of different microarrays.
BioCopy
DNA
RNA
PROTEINS

Applications
Our BioCopy patents cover more than 50 different applications. They range from vaccine precursor identification to complex high throughput molecular binding screenings.
Vaccine precursor screening
Vaccines are among the most important medicines of modern times. Here at BioCopy, we are developing a novel approach to significantly reduce the time required to identify vaccine precursors.
Latest News

Webinar on Thursday, April 15, 4:30 – 5:30 pm, CET: BioCopy presents its innovative COVID-19 mutant mapping platform for developing new vaccines.
BioCopy will showcase in a webinar its biomolecule copier in collaboration with Sino Biological, a global leader in recombinant technology,...
BioCopy Holding AG and Institute of Virology and Immunology (IVI) announce collaboration on African swine fever
Unlike classical swine fever, there is no vaccine against African swine fever. However, it has enormous economic potential. Just one...
Escape mutants: BioCopy files patent application to develop future broad-spectrum vaccines
The new process, based on BioCopy’s copying technology, should enable to design vaccines prophylactically against future mutants before they emerge,...
“Spin-offs To Watch 2021”: Forbes selects BioCopy as one of the 30 particularly most promising spin-offs in the DACH region
In the latest issue of Forbes, BioCopy with its copying and vaccine technology made it to the top 30 university...
Conference on the European healthcare industry in the Covid-19 crisis
BioCopy and CureVac present their contribution to the Covid-19 pandemic to representatives of the European Parliament and the European Commission...
Swiss start-up BioCopy revolutionizes vaccine development
The Swiss journal moneycab published an overview of BioCopy’s innovations in vaccine discovery and diagnostics. Read article (German version only)